Convergence Investment Partners LLC Invests $1.20 Million in The Clorox Company $CLX

Convergence Investment Partners LLC purchased a new position in The Clorox Company (NYSE:CLX) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 11,931 shares of the company’s stock, valued at approximately $1,203,000.

Other hedge funds have also recently made changes to their positions in the company. Center for Financial Planning Inc. bought a new stake in shares of Clorox in the 3rd quarter worth approximately $25,000. Vermillion & White Wealth Management Group LLC bought a new position in Clorox in the 3rd quarter valued at approximately $25,000. Root Financial Partners LLC bought a new position in Clorox in the 3rd quarter valued at approximately $29,000. Darwin Wealth Management LLC bought a new position in Clorox in the 2nd quarter valued at approximately $29,000. Finally, Ameriflex Group Inc. lifted its position in Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after acquiring an additional 273 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Trading Down 0.8%

NYSE:CLX opened at $90.47 on Friday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The firm has a market capitalization of $10.94 billion, a price-to-earnings ratio of 14.69, a price-to-earnings-growth ratio of 0.47 and a beta of 0.59. The Clorox Company has a one year low of $84.70 and a one year high of $136.69. The business has a fifty day moving average price of $101.99 and a 200-day moving average price of $106.96.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.Clorox’s revenue was up .1% on a year-over-year basis. During the same period in the prior year, the business posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts forecast that The Clorox Company will post 5.63 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd were paid a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 5.5%. The ex-dividend date was Wednesday, April 22nd. Clorox’s dividend payout ratio is 80.52%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on CLX shares. JPMorgan Chase & Co. lowered their price objective on Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, May 1st. Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Weiss Ratings raised Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. Wells Fargo & Company lowered their price objective on Clorox from $110.00 to $100.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Finally, Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $103.73.

Insider Activity at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 0.63% of the stock is owned by company insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.